daily menu » rate the banner | guess the city | one on oneforums map | privacy policy | DMCA | news magazine

Go Back   SkyscraperCity > Asian Forums > India > Metropolitan Projects > Hyderabad

Hyderabad Project news from Hyderabad and Secunderabad



Reply

 
Thread Tools Rating: Thread Rating: 63 votes, 5.00 average.
Old June 5th, 2010, 12:50 PM   #1
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

Hyderabad - Biotech & Pharmaceutical Hub Updates

This thread is about the updates of biotech and pharmaceutical and Hospital industry in Hyderabad

Last edited by rizwan3; June 5th, 2010 at 01:03 PM.
rizwan3 no está en línea   Reply With Quote

Sponsored Links
 
Old June 5th, 2010, 12:53 PM   #2
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

http://en.wikipedia.org/wiki/Genome_Valley
http://www.genomevalley.in/default.htm
rizwan3 no está en línea   Reply With Quote
Old June 5th, 2010, 12:55 PM   #3
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

DRS Group forays into pharma business
Source:http://www.business-standard.com/ind...iness/96008/on


Hyderabad-based DRS Group today said it has made a foray into pharmaceutical business with the launch of its new division, DRS Labs.

The group, which has interests in transportation, logistics, supply chain management, warehousing and education, will inaugurate its first pharmaceutical manufacturing facility at Medchal in Hyderabad tomorrow.

DRS Labs will initially focus on contract manufacturing. It will have a capital of Rs 10 crore, the company said in a statement.

"There is a huge demand in the contract manufacturing space and with Indian drug manufacturing sector gaining international prominence, we felt this was the right time to launch DRS labs," DRS Group Director A K Agarwal said.

"The new division will commence its operations with contract manufacturing and we will target Rs 50 crore turnover in the first year," he added.

Its Hyderabad facility is spread over 9 acres of land and with a built-up area of 40,000 sq ft is fully equipped to manufacture over 300 tonnes of tablets, capsules, liquids and ointments per year.

Moreover, the facility will provide direct employment to 200 people and create indirect employment opportunities to over 300 people, it said.
rizwan3 no está en línea   Reply With Quote
Old June 5th, 2010, 12:57 PM   #4
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

Pharmexcil seeks global consultants
Source:http://www.livemint.com/2010/05/2722...onsul.html?h=B

The Pharmaceuticals Export Promotion Council (Pharmexcil) has invited global consultants to draw up a plan for a proposed India branding and export facilitation project.

The overseas project, which will be paid for by the market access initiative fund of the commerce ministry and part-financed by the council itself, envisages the setting up of drug regulatory compliance and liaison centres, warehouses, infrastructure and the hiring of staff for export promotion activities in the overseas markets.

Pharmexcil chairman Smitesh Shah said the draft should be ready in a couple of months as the consultants will be shortlisted soon.

The proposal, which is the first of its kind by an Indian export promotion council, has also been approved in principle by the commerce ministry, he said.

In the first phase of the project, the overseas centres will be set up in five countries—the US, the UK, Japan, Russia and Nigeria. It will be expanded to a few other emerging markets later.

“These five markets constitute a significant part of India’s drug exports. The plan to set up common facilities abroad is to help bring down export costs, and also to develop markets, especially for drug makers entering newly to these geographies,” said Shah. “We have to be closer to the markets where we can sell our capabilities.”

The main objective of this big investment is to make exporters familiar with target markets. The overseas centres will have special cells to help Indian companies handle regulatory compliance issues, customs documentation and sales and distribution activities along with warehousing facilities, he said.

Pharmexcil, set up to promote drug exports from the country, is headquartered in Hyderabad and has regional offices in Mumbai, New Delhi and Ahmedabad.
rizwan3 no está en línea   Reply With Quote
Old June 5th, 2010, 12:58 PM   #5
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

Indian Immunologicals to launch 4 vaccines in a yr

Source:http://www.ptinews.com/news/678356_I...ccines-in-a-yr
Immunologicals Ltd, a subsidiary of National Dairy Development Board, today said it will launch four vaccines in the next one year and will invest Rs 150 crore to set up a new manufacturing facility in Hyderabad.
"The new facility will come up by the middle of next year near Hyderabad in an area of 50 acres and will produce both animal and human vaccines," Indian Immunologicals Ltd(IIL) Managing Director K V Balasubramaniam said.

At present, the company has two vaccine manufacturing units in Ooty and Hyderabad.
rizwan3 no está en línea   Reply With Quote
Old June 5th, 2010, 12:59 PM   #6
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

Indian Immunologicals embarks on greenfield project with Rs 150 cr investment
Source:http://www.pharmabiz.com/article/det...740&sectionid=


In a major effort to expand its vaccine portfolio, the Hyderabad-based Indian Immunologicals Limited, a subsidiary of the National Dairy Development Board has invested Rs 150 crore for a Greenfield project coming up on 50-acres at the Karkapatla Bio-Tech phase-III Genome Valley in Hyderabad.
The new project will augment the production capacity of vaccines for human and animal healthcare. The project will be completed in three phases.

The Rs 261 crore company is known for its rabies vaccine Abhayrab, which is its flagship brand generating Rs 102 crore, Abhay-Vac 3 for Measles Mumps Rubella and Elovac B are among the key products in the human health segment. Its animal healthcare range comprises 27 products, of which 10 are biologicals and the remaining are antibiotics, antihelminthics(worm expulsion drugs), NSAIDs and anti parasitics.
rizwan3 no está en línea   Reply With Quote
Old June 5th, 2010, 01:01 PM   #7
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

AP, MP too lure BT cos
Source:http://www.deccanherald.com/content/...o-lure-bt.html

While Karnataka is busy playing host to the best of the lot in biotechnology sector at its three-day flagship event in the City, Madhya Pradesh (MP) and its neighbour Andhra Pradesh (AP) are doing their best to woo investors.


With revenue from biotech sector at around $3 billion in 2010 and ancillary industries $1 billion acording to Association of Biotechnology Led Enterprises (Able) study, it offers huge opportunities, representatives from both the states told Deccan Herald.

While, Andhra Pradesh is already home to several BT firms like GVK Bio Sciences, Nectra Therapeutics, Aptuit Laurus, Helvetica Industries, Matrix Laboratories et al, and boasts of Genome Valley, Hyderabad, IKP Knowledge Park and other projects, Madhya Pradesh is showcasing its upcoming BT park in Indore and the special packages for the sector.

The annual flagship event BioAsia: The Global Bio Business Forum, held in Hyderabad, has completed seven successful years and is hunting for investors and sponsors for its eighth edition scheduled in February 2011.

According sources from Federation of Asian Biotech Associations (Faba), biotech firm Lonza is bringing in about Rs 1,000 crore investment into AP, while French firm Rennaisance is setting up an anti-cancer drug facility slated
rizwan3 no está en línea   Reply With Quote
Old June 5th, 2010, 04:38 PM   #8
Prodigist
High-derabaD
 
Prodigist's Avatar
 
Join Date: Jul 2006
Location: Hyderabad
Posts: 1,643
Likes (Received): 127

@rizwan3 Thanks for taking the initiative... Been planning to do this for some time now..

Quote:
BIOTECH Center's Of Excellence in HYDERABAD

1.Center For Cellular and Molecular Biology(CCMB)

2.Centre for DNA Fingerprinting & Diagnostics (CDFD)

3.
International Crops Research Institute for the
Semi-Arid Tropics
(ICRISAT)

4.Acharya NG Ranga Agricultural University(ANGRAU)

5.
Indian Institute of Chemical Technology (IICT)

6.University of Hyderabad (UoH)


Quote:
Companies in ICICI Knowledge Park(IKP)

Advanta Biotech- agribiotech
Aptuit Laurus- process development
CJ Pharma Research
Diacel Chemicals
DuPont
EBR Pharma
Indigene Pharma
i-Trace Nanotech
ITW Perfomance Polymers
JK AgriGenetics
NEKTAR therapeutics
Onan Biotech
Ortin Biotech
Regain Biotechnology
Several other Contract Research firms as well


Dupont has its India R&D center in ICICI Knowledge Park on about
15 acres and focusses on Polymers, AgriBiotech, Nanotechnology Reserach

IKP Knowledge Park has a Life Science Incubator (LSI)to encourage and nurture startup companies and spin offs in pharmaceutical and biotechnology related areas with the support of National Science and Technology Entrepreneurship Development Board (NSTEDB) of Dept. of Science and Technology (DST) Government of India.

Also another highlight in Hyderabad attracting R&D is APTDC. Andhra Pradesh Technology Development And Promotion Center that helps in IPR Fillings

Last edited by Prodigist; June 16th, 2010 at 01:08 AM.
Prodigist no está en línea   Reply With Quote
Old June 5th, 2010, 04:59 PM   #9
Prodigist
High-derabaD
 
Prodigist's Avatar
 
Join Date: Jul 2006
Location: Hyderabad
Posts: 1,643
Likes (Received): 127


GENOME VALLEY


India's first and only state-of-the-art biotech cluster providing world-class infrastructure to over 100 biotech companies. Spread over 600 sq. kms, the Genome Valley is a natural cluster for biotech research, training, collaboration and manufacturing activities.


IKP Knowledge Park is located in a 200 acre campus in the heart of Genome Valley. Hyderabad. This is the first state-of-the-art biotech cluster in India for life sciences research, training, collaboration and manufacturing activities. Spread over 600 sq. kms. around the IKP Knowledge Park, the SP Biotech Park and the ICRISAT Agri-business Incubator, the Genome Valley provides world-class infrastructure facilities to over 100 biotech companies. A large number of R&D and academic institutions in and around the biotech cluster contribute to the knowledge and talent pool.


BIOASIA

Asia’s most Prestigious and Widely attended Bio Business Event. Organised by FABA(Federation of Asian Biotech Assosciations) in assosciation with AIBA(All India Biotech Assosciation) Govt of AP and CII.

Last edited by Prodigist; June 5th, 2010 at 05:13 PM.
Prodigist no está en línea   Reply With Quote
Old June 5th, 2010, 06:35 PM   #10
Prodigist
High-derabaD
 
Prodigist's Avatar
 
Join Date: Jul 2006
Location: Hyderabad
Posts: 1,643
Likes (Received): 127

SHAPOORJI PALLONJI BIOTECH PARK

photo copyright Divya Bhat


The Shapoorji Pallonji Biotech Park (SPBP) is spread over 300 acres near Hyderabad, India and is the first of its kind in the country. It is the hub of Genome Valley, India’s first state of the art biotech cluster for life science research, training and manufacturing activities.
Quote:
Companies currently here:

Albany Molecular Research Centre Pvt. Ltd.
Avesthagen
Biogenex
Biomax
Genotex
Indigen
Issar Pharma
KCP Biotech
TATA Chemicals
Vimta Labs
Plans For Phase II



Quote:
Companies Setting Up their centres in the current 1.2 million s.ft Phase II expansion

Uni-Sankyo
ITC
Symphony
Sandor
Biological E. among others
Phase I has 600000 sft

Last edited by Prodigist; June 5th, 2010 at 07:42 PM.
Prodigist no está en línea   Reply With Quote
Old June 5th, 2010, 06:44 PM   #11
Prodigist
High-derabaD
 
Prodigist's Avatar
 
Join Date: Jul 2006
Location: Hyderabad
Posts: 1,643
Likes (Received): 127

CARE Hospitals Acquires Da Vinci Robot @ Rs 10 crores


Quote:
Robot-assisted surgeries will soon be performed in Hyderabad as city-based Care Hospital has acquired the Da Vinci surgical robot, a mechanical arm which carries out orders with "millimeter precision".

It advances surgical precision and in cardiac, urological, gastro-intestinal and gynaec surgeries. Its advantages also include fast healing and decrease in human error during operations, Kapoor said.
Prodigist no está en línea   Reply With Quote
Old June 7th, 2010, 05:01 AM   #12
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

[QUOTE=Prodigist;58124191]SHAPOORJI PALLONJI BIOTECH PARK
[SIZE="1"]



Plans For Phase II




U are Very Much Welcomed Bhai.
Feels GoOd..
rizwan3 no está en línea   Reply With Quote
Old June 7th, 2010, 05:07 AM   #13
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

Biotech sector may witness Euro 200 mn investment

Special Correspondent

HYDERABAD: Representatives of Biogenesis, the Hyderabad Health Cluster and Provence Promotion Economic Development Agency of France, have expressed confidence that soon the bio-technology sector would see an investment of Euro 200 million.

At a press conference here on Sunday, Olivier Blin of Biogenesis and Mathieu Viz from the French Agency, respectively said they were visiting the city following the successful conduct of ‘Bio-Asia' in February, where several companies from France had expressed interest to set up facilities here.

They were meeting several interested persons/companies aimed at boosting the cluster here and also increasing bilateral trade and investment, said Prof. Olivier.

The Provence Partnership by the French Agency would be ideal for promotion of life sciences. The Provence was the fastest-growing region in France and, as a gateway to mainland Europe, was a strategic destination.

Mr. Viz said the Provence was known for hosting academic laboratories, like Luminy Immunology Centre and Oncology Research Institution of Pacli Calmettes, one of the most focussed networks of hospital/university programmes and clinical trials in France.
rizwan3 no está en línea   Reply With Quote
Old June 16th, 2010, 01:05 AM   #14
Prodigist
High-derabaD
 
Prodigist's Avatar
 
Join Date: Jul 2006
Location: Hyderabad
Posts: 1,643
Likes (Received): 127

CIPLA Plans To Invest In a Manufacturing Plant

Quote:
The JV partners had plans to invest over Rs 600 crore to create manufacturing facilities at Bangalore and Hyderabad to manufacture these drugs, Villoo Morawala Patell, chairman and managing director of Avesthagen had told Business Standard two years ago.
Prodigist no está en línea   Reply With Quote
Old June 16th, 2010, 01:08 AM   #15
Prodigist
High-derabaD
 
Prodigist's Avatar
 
Join Date: Jul 2006
Location: Hyderabad
Posts: 1,643
Likes (Received): 127

@rizwan : Can u please post the link of the article along.. And try to limit the parts of the article to whatever is relevant..
Prodigist no está en línea   Reply With Quote
Old June 21st, 2010, 08:23 AM   #16
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

Nuziveedu Seeds, 4th largest biotech firm in India’
Andhra Business Bureau

HYDERABAD: City-based Nuziveedu Seeds Limited emerged as fourth largest biotech firm India in terms of income while Benguluru-based Biocon topped the list with the total revenues of Rs 1,180 crore for the last fiscal, according to ABLE-BioSpectrum survey.

This 8th annual survey conducted by Association of Biotechnology Led Enterprises (ABLE) and BioSpectrum, a monthly journal, stated that Nuziveedi Seeds, the largest hybrid seed company in the country, sold seven million packets of Bt cotton seeds, which accounted for 36 per cent market last fiscal. It also retained number one position as rice seed supplier.

Biotech firms Serum Institute and Panacea were at 2nd and 3rd positions while the India’s biotech industry grew by 17 per cent during 2009-10 to $3 billion. Another city-based firm Shantha Biotech came at 9.

According to the survey, which was based on 150 biotech firms in the country, south India continues to remain India’s largest biotech cluster in terms of the number of companies. The region is home top 172 biotech companies, which have posted revenues of Rs 5,537.68 crore last fiscal, which constitutes 39 per cent of the overall revenues.

Western India, though home to 137 companies, continued to dominate India’s biotech industry with 46 per cent share in the overall revenues of Rs. 14,199 crore. The 137 companies in the region clocked Rs. 6,631 crore during the year increasing the region’s share in the overall revenues by 3 per cent over 2008-09, thus gaining a lead of 6 per cent over South.

Mumbai outpaced Benguluru in biotech space and emerged as India’s top biotech city in terms of revenue as it generated Rs 200 more income from this crucial sector than the garden city.
rizwan3 no está en línea   Reply With Quote
Old June 28th, 2010, 05:36 AM   #17
kdlara007
Registered User
 
Join Date: Nov 2008
Posts: 182
Likes (Received): 10

Exclamation Referring to the news article below published in Feb, 2007,Does aany body know whether the supposed Hyderabad and Vizag projects are being implemented or deferred or completely shelved?7, D

Quote:
Originally Posted by rizwan3 View Post
This thread is about the updates of biotech and pharmaceutical and Hospital industry in Hyderabad
AP pips B'lore in Biocon deal
TNN, Feb 17, 2007, 02.26am IST

Article
Comments




HYDERABAD: The IT City has just lost another project to Andhra Pradesh. Biocon has decided to set up a Rs 1,000-crore manufacturing facility at Jawahar Pharma City, a special economic zone (SEZ) near Visakhapatnam.

Announcing this, Biocon chairman and managing director Kiran Mazumdar-Shaw said the company would become one of the major anchor investors in the SEZ.

The SEZ is being developed by Ramkey group. Shaw who was in AP to participate in the Bio-Asia conference told TOI, "Karnataka does not provide any infrastructural support for industries such as ours, while the Andhra Pradesh government is keen to do so. In Bangalore, the IT and hardware industries get all support."

A 50-acre spread has been allotted for the same by chief minister Y S Rajasekhara Reddy, who handed over the allotment letter to Shaw on Friday.

The company is also taking a 10-acre land in a biotech SEZ in Hyderabad to be developed by Andhra Pradesh Industrial Infrastructure Company.

Shanta Bio is the anchor client for this SEZ. The Vizag SEZ has a state-of-the-art effluent treatment plant with marine discharge facility.

AP has promised Biocon uninterrupted power and water supply. "Karnataka does not seem to be aware of the needs of our industry. Effluent treatment is expensive; captive power generation is also very costly. The state has become too expensive. Hence,we have thought of an alternative location for our second facility in India,"she said.

Biocon has a huge R&D facility in Bangalore. "We have decided to carry out only research activities at our Bangalore facility.

All manufacturing-related work will be done at Vizag,"she said. AP has been keen to get Shaw to invest in the state ever since it realised that the biotech major is unhappy over the lack of infrastructural support in Bangalore.

According to sources in Pharma City, Biocon is likely to invest Rs 700 crore in the first phase,which is likely to completed within one year.

"The manufacturing facility will be catering to the Biocon's global needs. It'll also be one of the biggest facilities for the company. The unit will employ about 2,000 people when it is fully operational,"Pharma City chief executive Eswar Reddy told TOI.
kdlara007 no está en línea   Reply With Quote
Old June 30th, 2010, 08:00 AM   #18
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

Model N to invest $25 mn in Hyderabad facility
BS Reporter / Chennai/ Hyderabad June 30, 2010, 0:58 IST

Model N Inc, a Silicon Valley-based revenue management solutions provider, will be investing $25 million (approximately Rs 117 crore) in its India operations at Hyderabad over the next three years, according to Zack Rinat, its founder and chief executive officer.

Announcing the launch of its Hyderabad centre on Tuesday, the company’s third with the other two located at Redwood Shores in the US and London, Rinat said the centre at present housed 105 professionals, which would be scaled up to 250 by the end of September 2011. The privately-held company follows the October-September financial year.


“Our decision to establish our Asia headquarters in Andhra Pradesh was largely driven by chief minister K Rosaiah’s vision for the region to become a hub for the pharmaceutical and high-tech industries,” he added.

The Hyderabad centre will be engaged in product development, professional services, application support, product management, quality assurance, customer support and documentation, with primary focus on the pharmaceutical, life sciences and high-tech marketplace.

Model N currently has a revenue management suite comprising 14 applications, and has over 40,000 end users in the high-tech space. Talking about revenue management, Rinat said for every $1 billion of revenues, companies leave anywhere between $40 million and $120 million on the table.


India is projected to be the 10th largest pharmaceutical market by 2015, and is set to be positioned among the top five markets with a $20-billion size in absolute growth terms by then,” he said, adding that the company was expecting the Asia-Pacific region to contribute 20 per cent to its global revenues over a period of time.

Last edited by rizwan3; June 30th, 2010 at 08:06 AM.
rizwan3 no está en línea   Reply With Quote
Old July 21st, 2010, 10:20 PM   #19
Prodigist
High-derabaD
 
Prodigist's Avatar
 
Join Date: Jul 2006
Location: Hyderabad
Posts: 1,643
Likes (Received): 127

Now, a brain pacemaker to reduce symptoms of Parkinson's disease


Quote:
HYDERABAD: Deep brain stimulation, a complicated surgery also known as the pacemaker for the brain, is fast evolving into a reliable therapy for Parkinson's disease.


A team of neurosurgeons of the Nizam's Institute of Medical Sciences (NIMS) has managed to achieve an improvement of 80 per cent in the condition of patients crippled by Parkinson's.


The team has conducted close to 90 successful surgeries, helping patients lead a life of independence and dignity. While pacemakers for the brain may not cure Parkinson's, neurologists say the therapy has drastically reduced the symptoms and managed to improve the quality of life.
Deep brain stimulation involves placing electrodes in the ‘sub-thalamus' region of the brain. The electrodes are connected to a pacemaker (Implantable Pulse Generator) which sends electrical signals to the brain to stimulate its activity.


The pacemaker is placed just below the collar bone, and runs on a battery, which has a shelf life of five years. Doctors programme the pacemaker to deliver appropriate stimulation to the brain.
Prodigist no está en línea   Reply With Quote
Old July 28th, 2010, 02:11 PM   #20
rizwan3
Registered User
 
rizwan3's Avatar
 
Join Date: Sep 2009
Location: Hyderabad
Posts: 1,009
Likes (Received): 14

Narayana Hrudayalaya plans seven more health cities


Chief Minister inaugurates 500-bed multi-speciality hospital at Jeedimetla

HYDERABAD: The Bangalore headquartered Narayana Hrudayalaya Hospitals with presence in seven cities, including Hyderabad, will open hospitals in seven more cities in the next two or three years.

After Chief Minister K. Rosaiah formally inaugurated the 500-bed Narayana Hrudayalaya-Malla Reddy multi-speciality Hospital at Jeedimetla on Tuesday, Dr. Devi Shetty, Group Chairman, said their aim was to provide 30,000 hospital beds in the next seven years across the country.

The Rs.100 crore first phase of hospital where 100 heart surgeries were performed in the last four months would eventually be developed into a 5,000-bed health city.

“Our objective is to develop health cities with 2,000 to 5,000 beds to address the requirement of 1.2 billion nation,” he said.

Hi-tech health care

Dr. Devi Shetty, who pioneered the Yeshaswini micro health insurance scheme for farmers in Karnataka, appreciated the State government's Rajiv Arogyasri health insurance. With health insurance schemes, it was possible to provide hi-tech health care to masses, he asserted.

Infosys Technologies Chairman and Chief Mentor Narayanamurthy, who had set up venture capital fund Catamaran with plans to help entrepreneurs in healthcare apart from other sectors, said that despite India's great growth story, lack of access to health and education to majority population remained a serious concern.

rizwan3 no está en línea   Reply With Quote


Reply

Thread Tools
Rate This Thread
Rate This Thread:

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off



All times are GMT +2. The time now is 05:00 PM.


Powered by vBulletin® Version 3.8.8 Beta 1
Copyright ©2000 - 2014, vBulletin Solutions, Inc.
Feedback Buttons provided by Advanced Post Thanks / Like v3.2.5 (Pro) - vBulletin Mods & Addons Copyright © 2014 DragonByte Technologies Ltd.

vBulletin Optimisation provided by vB Optimise (Pro) - vBulletin Mods & Addons Copyright © 2014 DragonByte Technologies Ltd.

SkyscraperCity ☆ In Urbanity We trust ☆ about us | privacy policy | DMCA policy

Hosted by Blacksun, dedicated to this site too!
Forum server management by DaiTengu